- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 874
Sols Systems walks away with funding
3D printed orthotic company, Sols, gains $1.75m in seed funding led by Lux Capital.
Apr 1, 2014Rise Labs raises healthy investment
Rise Labs, creators of a nutrition and lifestyle coaching smart phone app, has raised $2.3m in funding led by Floodgate with participation from Google Ventures.
Apr 1, 2014$2.8m funding for Transcriptic
US-based Transcriptic, a Google-backed provider of automated scientific services, has raised an additional $2.8m in financing led by IA Ventures.
Apr 1, 2014Losing pounds gains dollars for Noom
Noom, a US-based health and fitness application company, has raised $7m in series A funding led by RRE Venures and including Qualcomm.
Apr 1, 2014Jaguar snags $2m in funding
Jaguar Animal Health, headquartered in San Francisco and backed by Napo Pharmaceuticals, has closed its series A funding round led by BioVeda China Fund with an investment of $2m.
Apr 1, 2014UniQure raises $91.8m in IPO
UniQure, a gene-therapy company based in The Netherlands, has closed its initial public offering which raised $91.8m by selling 5.4 million shares of common stock.
Apr 1, 2014scPharmaceuticals closes series A with $16m
Lundbeck's corporate venturing unit has co-led company's series A round, and the funds will be used to develop the pipeline for its two lead treatment options.
Mar 31, 2014RuiYi looks to China after $15m round
Merck Serono and GlaxoSmithKline have both invested in a $15m round for the biopharmaceutical company, which is focusing its treatments on the Chinese market.
Mar 31, 2014Intel eyes promise in OrCam's vision
Intel's corporate venturing unit has invested a reported $15m in OrCam Technologies, which is developing special eyeglasses to help the blind.
Mar 31, 2014AGTC sees $50m in proceeds from IPO
The biopharmaceutical company, which has investors including the corporate venturing subsidiaries of GlaxoSmithKline and MedImmune, has secured $50m from its initial public offering.
Mar 31, 2014About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


